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Abstract 
 
Tea catechin is one of the compounds that are closely related to obesity and insulin sensitivity. In order to 
determine the effect of catechin on adipocyte differentiation, we treated 3T3-L1 preadipocytes with different 
kinds of catechins. Our results showed that catechins, especially epigallocatechin gallate (EGCG), significantly 
reduced intracellular lipid accumulation and repressed the activity of glycerol-3-phosphate dehydrogenase, an 
enzyme involved in lipid synthesis. Furthermore, glucose and fatty acid transport were also suppressed by 
catechin. We then analyzed the activity of transcription factors––forkhead transcription factor class O1 
(FoxO1) and sterol regulatory element-binding protein-1c (SREBP1c)––which are involved in adipocyte 
differentiation and lipid synthesis, respectively. The transcriptional activities of both these factors significantly 
decreased by EGCG. Western blot analysis revealed that EGCG induced the insulin signal-mediated 
phosphorylation of FoxO1 (Thr24, Ser256). These results suggest that EGCG suppresses the differentiation of 
adipocytes through the inactivation of FoxO1 and SREBP1c.  
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Abbreviation 
Akt: protein kinase B  
CG: (-) catechin gallate 
DMEM: dulbecco’s modified eagle’s medium 
EGCG: (-) epigallocatechin gallate  
ECG: (-) epicatechin gallate 
EGC: (-) epigallocatechin  
FoxO: forkhead transcription factor class O 
GPDH: glycerol-3-phosphate 
GAPDH: glyceraldehyde-3-phosphate dehydrogenase 
IGF-1: insulin-like growth factor1 
IRS: insulin receptor substrates 
MTT: 3-(4, 5-dimetyl-2-thiazolyl)-2, 5-diphenyltetrazolium bromide 
2-NBDG: 2-(n-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl) amino)-2-deoxyglucose  
PI3K: phosphatidyl inositol 3 kinase 
ROS: reactive oxygen species 
SREBPs: sterol regulatory element binding protein 
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Introduction 
 
The recent increase in the number of patients with lifestyle-related diseases such as high blood pressure, 
hyperlipemia, cancer, heart disease, diabetes due to obesity, and metabolic syndromes related to eating habits 
has become a problem in developing countries (Deitel M 2003). Obesity is a complex disorder caused by both 
genetic and environmental factors. Although the correlation between obesity and insulin sensitivity should be 
well understood, so far, little is known. Hormones such as insulin and insulin-like growth factor 1 (IGF-1) 
conjunct with the IGF-1 receptor and activate the insulin signaling cascade; this in turn induces 
phosphatidylinositol-3 kinase (PI3K) to activate Akt (protein kinase B) via insulin receptor substrates (IRSs) 
(Longo VD and Finch CE, 2003). Forkhead transcription factor class O (FoxO) proteins have highly conserved 
phosphorylation sites (Thr24, Ser256, and Ser-319 in human FoxO1) (Nakae J, Park BC, and Accili D 1999) 
that are targets of phosphorylation by Akt. Phosphorylated FoxO is transported from the nucleus to the cytosol, 
resulting in its eventual inactivation (Muslin AJ and Xing H, 2000). The FoxO family is composed of the 
subtypes FoxO1, FoxO3, and FoxO4 (Ogg et al 1997). In a recent study, Nakae et al. reported that FoxO1 
specially inhibits adipocyte differentiation via insulin signaling (Nakae J and Tadahiro K 2003), whereas we 
revealed that knockdown of FoxO1 mRNA expression markedly suppressed adipocyte differentiation 
(Munekata K and Sakamoto K 2009). Those results suggest that FoxO1 plays an essential role in adipocyte 
differentiation. Moreover, it is known that reactive oxygen species (ROSs) interfere with insulin signaling and 
causes apoptosis via FoxO activation (Hansen LL et al 1999). 
Sterol regulatory element-binding proteins (SREBPs) regulate the expression of genes that control fatty 
acid and cholesterol synthesis. SREBPs are composed of 3 subtypes: SREBP1a (Christenson KL et al 2001), 
SREBP1c (Tontonoz P et al 1993), and SREBP2 (Hua X et al 1993). SREBP1c prevents fatty acid synthesis, 
SREBP2 prevents cholesterol formation, and SREBP1a prevents both cholesterol formation and fatty acid 
synthesis. SREBP1c, in particular, is expressed remarkably in the liver and adipocytes and is regulated by 
nutritional state. Generally, the SREBP1c-SCAP complex is transported to the Golgi complex in response to 
stimulation by insulin or glucose (Nohtufft A et al 1998). In addition, activated SREBP also promotes the 
expression of glucose and fatty acid synthesis enzymes. We also revealed the fact that ROSs accelerate 
SREBP1c transcriptional activity (Sekiya M et al 2008). 
In general, ROSs are involved in a variety of physiological cell processes. Low levels of ROSs induce the 
expression of ROS scavenger enzymes (catalase, glutathione peroxidase, or super oxide dismutase) as a 
cellular antioxidant protective mechanism (Wang JF et al 2004). High levels of ROSs cause cancer, aging, and 
neurodegenerative disorders by damaging cells and DNA (Hussain SP et al 2003; Martindale JL and Holbrook 
NJ 2002). Moreover, ROSs act as second messengers that regulate the function of the target proteins through 
phosphorylation and oxidation of cysteine residues (Cross JV and Templeton DJ 2006). In addition, it is 
known that ROSs mediate dephosphorylation of Akt, causing apoptosis (Cao J et al 2009). Further, catechins 
are polyphenols that possess antioxidant activities. EGCG is the strongest antioxidant in green tea polyphenols 
and prevents neurodegenerative diseases (Mendel S and Youdim MB 2004), streptozotocin-induced diabetes 
(Song EK et al 1999), cancer (Ahmad N and Mukahtar H 1999; Liao S et al 2001; Lin JK et al 1999; Mitcher 
LA 1997; Yang CS and Wang ZY 1993), and collagen-induced arthritis (Haqqi TM et al 1999) that are caused 
by oxidative stress. In addition, EGCG can reduce body weight and body fat. Injection of EGCG into rats 
lowers both blood glucose and insulin levels (Kao YH et al 2000). EGCG may also participate in insulin 
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signaling because superoxide scavengers such as N-acetylcysteine (NAC) induce the activation of PI3K 
(Waltner-Law ME et al 2002).                                               
Generally, adipocytes play a central role in maintaining energy balance by storing triacylglyceroles (TGs) 
and releasing free fatty acids (FFAs) (Fruhbeck G et al 2001). The mouse preadipocyte cell line, 3T3-L1, has 
the capability to differentiate into adipocytes when treated with dexamethasone, 3-iso-butyl-1-methylxanthine, 
and insulin (DMI) (Rubin CS 1978). It is easy to determine the molecular mechanism of catechin by analyzing 
the mechanism of differentiation in detail. 
In this report, we aimed to determine the physiological function of EGCG and elucidate its molecular 
mechanism underlying adipocyte differentiation via the insulin signaling cascade. In particular, we focused on 
the transcription factors FoxO and SREBP1c that participate in adipocyte differentiation and lipid synthesis. 
 
 
Materials and Methods 
 
Cathechins. (-) Epigallocatechin gallate (EGCG), (-) Epicatechin gallate (ECG), (-) Epigallocatechin 
(EGC), (-) Catechin gallate (CG) were provided from Mitsui Norin (Minato, Tokyo, Japan). The catechins used 
in this study were dissolved in methanol and stored at -20 °C. 
 
Cell culture. The 3T3-L1 cells (Health Science Research Resources Bank, Sennan, Osaka, Japan) were 
cultured at 37 °C in Dulbecco’s modified Eagle’s medium (DMEM High-glucose) supplemented with 10% 
FBS (Sanko Junyaku, Chiyoda, Tokyo, Japan). After the confluence, cells were cultured for 2 days with 0.25 
µM Dexamethason (Sigma-Aldrich), 0.5 mM 3-iso-butyl-1-methylxanthine (Sigma-Aldrich) and 10 µg/ml 
insulin (Wako, Chuo, Osaka, Japan) (DMI induction). Then cells were cultured in media containing 5 µg/ml 
insulin for 2 days, and in standard culture media for 4 days (Rubin CS 1978). 
 
Oil red O staining. Cells were cultured in media containing DMI and catechin (EGCG, ECG) (0, 50, 100 
200 µM) for 2 days and in standard culture media for 6 days. Cells were fixed with 4% paraformaldehyde for 1 
hr, and then dyed with 3 mg/ml Oil red O (in 60% isopropanol) for 10 min. After washing, cells were observed 
under microscope (DMIRBE M2FLIII (Leica Microsystems Inc., Bannockburn, IL, USA)). In addition to the 
aforementioned, the dye was eluted for 10 min with 100% isopropanol. The concentration of the eluted dye 
was determined from measurements of absorbance (O.D. 420 nm). 
 
Triglyceride assay. Cells were lysed in lysis buffer (20 mM HEPES [pH 7.6], 420 mM Nacl, 1% Triton 
X-100, 0.1% SDS) and total fat was extracted by Bligh and Dyer method (Bligh EG and Dyer WJ 1959). The 
cell extract (600 µl) was incubated in 2 ml methanol and 1ml chloroform for 1 hr, and then 1 ml chloroform 
and 1 ml of sterile water were added, centrifuged briefly to collect the chloroform phase. This extract was dried 
for overnight, and was dissolved in 10% trition-isopropanol solution. According to manual of triglyceride 
E-test Wako (Wako Chuo, Osaka, Japan), the quantity of triglyceride was measured. The quantity of 
triglycerides (µg/µl) was normalized by each protein contents. 
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GPDH assay. Cells were treated with supersonicator (UP-50H, B. Braun Biotech International GmbH, 
Melsungen Germany) for 2 min, and the cell extract was collected after centrifugation (4 °C, 21,206 g, 10 min, 
MX-100, Tomy, Tokyo, Japan). The protein concentration was quantified using the BCA protein assay kit 
(Pierce, Rockford, IL, USA). The protein (100 µg) was added to TAE solution (0.5 M Tris [pH 8.0], 10 mM 
EDTA, 10 mM β- mercaptoethanol), 5 mM dihydroxyacetone phosphate, 0.5 mM NADH, dDW at 37 °C, 20 
min, 65 °C, 5 min and analyzed by measuring O.D. 340 nm. 
 
MTT assay. Cells cultured in DMEM medium were treated with catechin (EGCG, ECG) (0, 10, 50, 100, 
200 µM) for 2 days and then treated by 5 mg/ml MTT (3-(4, 5-Dimetyl-2-thiazolyl)-2, 
5-diphenyltetrazoliumbromide) solution (Sigma) for 3 hrs. After cells were dissolved in 0.04 N HCl (in 
isopropanol), formazane level was analyzed by measuring O.D. 570 nm (against O.D. 630 nm). 
 
Glucose transport. Cells were cultured in media containing DMI induction and catechin (EGCG, ECG 
100 µM) for 2 days. After 6 days culture, cells were treated with KRP-H buffer (131.2 mM NaCl, 4.7 mM KCl, 
2.5 mM NaH2PO4, 2.5 mM CaCl2, 1 mM MgSO2, 1 mM HEPES [pH 7.4] containing 10 µM 2-NBDG (2- (N- 
(7-nitrobenz-2-oxa-1, 3-diazol-4-yl) amino) -2- deoxyglucose) (Invitrogen Life Technologies, Carlsbad, CA, 
USA) at 37 °C for 5 min. After washing the cells with KRP-H buffer, cells were observed under a LEITZ 
DMRXA HC RXA-6 fluorescence microscope (Leica).   
 
Fatty acid transport. Cells were cultured in a media containing DMI and catechin (EGCG, ECG 100 µM) 
for 2 days. After 6 days culture, cells were treated with 20 µM BODIPY3823 (Invitrogen) and 20 µM BSA 
(fatty acid free) at 37 °C for 2 min. After 20 µM BSA treatment, cells were observed under a LEITZ DMRXA 
HC RXA-6 fluorescence microscope (Leica).   
 
Luciferase assay. COS7 cells were transfected with FoxO1 expressing plasmid (pcDNA3-FoxO1, 0.25 
µg/dish), luciferase reporter plasmid with a consensus sequence of FoxO1 binding site (IRS-Luc, 0.5 µg/dish) 
and β-galactosidase expressing plasmid (PCMV-β-gal, 0.25 µg/dish). After 45 hrs incubation, cells were 
treated with EGCG (0, 10, 20, 50 100 µM) for 3hrs. We prepared the DNA fragments which carry the genomic 
sequence (Catalase promoter region; Catalase) of FoxO binding site, and the consensus sequence (SREBP-1c 
responsive element; SRE) of SREBP-1c binding site. The luciferase reporter plasmids with a FoxO DNA 
binding site (Catalase-Luc) and with a SREBP-1c DNA binding site (SRE-Luc) were constructed. The stable 
3T3-L1 cells which carry Catalase-Luc or SRE-Luc were prepared (3T3-L1/Catalase-Luc, 3T3-L1/SRE-Luc). 
These cells were treated with catechin (100 µM of EGCG, ECG, EGC), resveratrol (100 µM) and 
N-acetylcystein (10 mM) for 2 days. After, brief centrifugation (15,800 g, 2 min, MX-100, Tomy, Tokyo, 
Japan) of the cell lysate, supernatant was collected and mixed with Luciferase Assay Reagent (Promega). 
Luciferase activity was measured with a Luminometer Microlumat LB69p (Berthold Technology, Germany).  
 
Real-time PCR. Quantitative PCR analysis was performed with an Gene Amp 5700 Sequence Detection 
System (Applied Biosystems, CA, USA) and Thunder Birds SYBR qPCR mix reagent (TOYOBO, Kita, Osaka, 
Japan). PCR (95 °C for 15 s, 60 °C for 1 min, for 40 cycles) was performed using the specific primers 
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(5′-AAACTCTGGGAGATTCTCCT-3′ and 5′-TGGCATCTCTGTGTCAAC-3′) for PPARγ, 
(5′-GCCAAACTGAGACTCTTC-3′ and 5′-GGAAGCCTAAGTCTTAGC-3′) for C/EBPα, and (5′- 
CTGTGCTGCTCACCGAGG-3′ and 5′-AGCCTGGATGGCTACGTA-3′) for β-actin. β-actin was used as an 
internal standard for correction of the error determined between each sample. 
 
RT-PCR. The cDNA was synthesized using M-MLV Reverse Transcriptase (Takara Bio, Otsu, Shiga, 
Japan), and PCR (95 °C for 5 min; 25-40 cycles of 95 °C for 30 sec, 57 °C for 30 sec, 72 °C for 1.5 min; 72 °C 
for 7 min) was performed using the specific primers (5’-GATCTACGAGTGGATGGT-3’ and 
5’-CAGCGTAGACGCCATCTT-3’) for FoxO1, (5’-TTGTACCACTGGTAGAGC-3’ and 
5’-CTGTGGCCTCATGTAGGAAT-3’) for SREBP1c, (5’-GACCCCTTCATTGACCT-3’ and 
5’-CCACCACCCTGTTGCTGT-3’) for GAPDH (glyceraldehyde-3-phosphate dehydrogenase). 
 
Western blotting. Cells were suspended in a sample buffer (50 mM Tris-HCl [pH 6.8], 2% SDS, 6% 
β-mercaptoethanol, 10% glycerol) containing protease inhibitors (1 mM AEBSF, 130 µM Bestatin, 14 µM 
E-64, 1 mM EDTA, 1 µM pepstatin A). Then cells were treated with supersonicator (UP-50H, B. Braun 
Biotech International GmbH, Melsungen Germany) for 2 min, and the cell extract was collected after 
centrifugation (4 °C, 21,206 g, 10 min, MX-100, Tomy, Tokyo, Japan). The protein concentration was 
quantified using the BCA protein assay kit (Pierce, Rockford, IL, USA). SDS-PAGE was performed with 80 
µg of protein and the separated proteins were transferred to a PVDF membrane (Schleicher & Schuell 
BioScience, Keene, NH, USA). Non-specific binding was blocked by soaking the membrane in 5% skim milk. 
The membrane was then incubated with the primary antibody overnight followed by incubation with the 
secondary antibody for 1 hr and detection of specific binding using the Lumi GLO reagent (Cell Signaling, 
Danvers, MA, USA). Finally, each protein band was detected by chemiluminescence (Las 1000, Fuji FILM, 
Minato, Tokyo, Japan), and analyzed with Image Gauge Software (FUJI-FILM). Anti-FoxO1 (Cell signaling), 
anti-phospho-FoxO1 (Thr24) (Cell signaling), anti-phospho-FoxO1 (Ser256) (Cell signaling) and anti-β-actin 
(Sigma) were used as primary antibodies. 
 
 
Results 
 
Effect of catechin on fat accumulation 
3T3-L1 cells were treated with DMI and catechin (EGCG, ECG) (0, 50, 100, 200 µM) for 2 days. After 6 
days of culturing, cells were dyed and observed. We showed that the differentiation of 3T3-L1 cells was 
suppressed by catechin in a dose dependent manner (Fig. 1A), and ECG was found to exert a stronger 
suppressive effect than EGCG. In addition, we extracted the dye from the cells and measured its absorbance 
(optical density (OD. 420 nm)) (Fig. 1B). As observed in Figure 1A, several kinds of catechin suppressed 
adipocyte differentiation, and the suppressive effect of ECG was more remarkable than EGCG. Under the same 
conditions, we also examined the accumulation of triglyceride and found that catechin treatment reduced its 
accumulation (Fig. 1C). Treatment with NAC also resulted in reduced triglyceride accumulation. Because 
intracellular level of reactive oxygen species (ROS) generated during adipocyte differentiation was reduced by 
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either EGCG and NAC treatment (data not shown), EGCG possibly prevented fat accumulation in 3T3-L1 
mainly through the antioxidant activity of catechin.  
To elucidate the role of catechin in the prevention of adipocyte differentiation, we analyzed GPDH 
activity, a parameter of fat synthesis in adipose tissues and adipocytes. As observed in Figure 1, catechin also 
reduced GPDH activity (Fig. 2). We used EGCG and ECG (0, 10, 50, 100, 200 µM); the latter exerted the 
highest suppressive effect on 3T3-L1 cell differentiation. Cell viability was determined by the MTT assay. 
EGCG and ECG treatments did not change cell viability (data not shown). 
Next, we investigated glucose and fatty acid incorporation to determine the suppressive effect of catechin 
on adipocyte differentiation. We exposed differentiated 3T3-L1 cells to fluorescent-labeled glucose (2-NBDG) 
and observed them under a fluorescence microscope. We observed that catechin inhibited glucose 
incorporation (Fig.3). Simultaneously, differentiated 3T3-L1 cells were exposed to the fluorescent-labeled fatty 
acid analog BODIPY3823 instead of 2-NBDG. As observed in Figure 3, catechin also remarkably reduced 
fatty acid incorporation (Fig.4). 
 
Effect of catechin on the transcriptional activity of FoxO1 and SREBP1c 
To analyze the effect of EGCG on the activity of FoxO1, COS7 cells were treated with varying 
concentrations of EGCG (0, 10, 20, 50, 100 µM) for 3 hrs and analyzed with the luciferase assay. EGCG 
reduced the transcriptional activity of transiently introduced-FoxO1 in COS7 cells at the concentration of 100 
µM (Fig. 5A). We also prepared 3T3-L1 cells that carry luciferase reporter plasmids with a FoxO1 binding site 
of catalase promoter (3T3-L1/Catalase-Luc) and with a consensus sequence of SREBP1c binding site 
(3T3-L1/SRE-Luc). The effects of catechin on the transcriptional activity of these cells were determined. We 
treated cells with catechin (EGCG, ECG, EGC), resveratrol, and NAC for 2 days, then analyzed them with the 
luciferase assay. Catechin, resveratrol, and NAC reduced the transcriptional activity of FoxO1 (Fig. 5B). 
Although ECG more strongly suppressed lipid accumulation as compared to EGCG (Fig. 1), it did not 
significantly decrease FoxO1 transcriptional activity. As shown in Figure 5B, EGCG reduced SREBP1c 
transcriptional activity (Fig. 5C). These results indicate that EGCG suppressed the differentiation of the 
adipocytes by reducing the transcriptional activity of FoxO1 and SREBP1c through its antioxidant effect. 
 
Effect of catechin on mRNA and protein expression of FoxO1 and SREBP1c 
To elucidate the signaling through which EGCG acts on differentiation of 3T3-L1, real-time PCR was 
performed to analyze the endogenous mRNA expression of clonal expansion-related genes, including PPARγ 
and C/EBPα. As observed in Figure 6A, EGCG remarkably reduced mRNA expression of PPARγ and C/EBPα. 
These results suggest that EGCG arrest the differentiation by reducing mRNA expression of PPARγ and 
C/EBPα in 3T3-L1. Then, we used RT-PCR to analyze the mRNA expression of FoxO1 and SREBP1c. EGCG 
treatment did not affect FoxO1 and SREBP1c mRNA expression (Fig. 6B). Figure 5 shows that EGCG 
remarkably reduced FoxO1 transcriptional activity; therefore, we analyzed Akt-dependent FoxO1 
phosphorylation because its activity is regulated by insulin signaling. Although FoxO1 protein expression was 
not affected by catechin (EGCG, ECG) treatment (as compared to β-actin), there was increased 
phosphorylation at residues Thr24 and Ser256, which are targets of Akt (Fig. 6C). In addition, NAC treatment 
resulted in increased FoxO1 phosphorylation. These results suggest that the antioxidant effect of catechin 
suppressed insulin signaling. 
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Discussion 
 
Our results clearly revealed that catechin suppressed the differentiation of preadipocyte 3T3-L1 cells. 
Resveratrol and NAC, which have antioxidant activities, similarly suppressed 3T3-L1 differentiation. These 
results suggest that the antioxidant activity of catechin inhibits adipocyte differentiation. Actually, a catechin 
decreased the accumulation of ROS generated during the differentiation process of adipocyte (data not shown). 
Since it is reported that catechin decreases blood insulin levels (Kao YH, Hiipakka RA, and Liao S 2000), it is 
possible that the ability of catechin to inhibit differentiation is associated with insulin signaling. 
In this experiment, we suspected that catechin may inhibit adipocyte differentiation through its regulation 
of a transient cell proliferation stage known as clonal expansion since the 3T3-L1 cells were treated with DMI 
and catechin for only the first 2 days. It was recently reported that the FoxO family inhibits the clonal 
expansion stage (Nakae J and Tadahiro K 2003). Nakae et al. suggested that FoxO1 participates in 
differentiation, whereas we clarified the fact that the differentiation of 3T3-L1 preadipocytes infected with an 
adenovirus expressing FoxO1-siRNA was markedly inhibited (Munekata K and Sakamoto K 2009). It is 
known that FoxO proteins have highly conserved phosphorylation sites (Thr24, Ser256, Ser319 in human 
FoxO1), which are phosphorylated by Akt (Longo VD and Finch CE 2003). Phosphorylated FoxO is 
transported from the nucleus to the cytosol, resulting in its inactivation (Muslin AJ and Xing H 2000). In this 
study, EGCG reduced FoxO1 transcriptional activity in COS7 cells (Fig. 5A) and 3T3-L1 cells (Fig. 5B). 
Therefore, we think that the inhibition of the adipocyte differentiation by catechin is at least partially caused by 
the inactivation of FoxO. To study the modification of the FoxO protein in insulin signaling, we analyzed the 
Akt-dependent phosphorylation of FoxO and observed that catechin increased FoxO1 phosphorylation (at sites 
Thr24, Ser256) (Fig. 6C). Additionally, since ROSs result in the dephosphorylation of Akt (Cao J et al 2009), 
we think that the antioxidant effect of EGCG may promote the phosphorylation of Akt, resulting in the 
phosphorylation and inactivation of FoxO1. 
The transcriptional activity of SREBP1c, which regulates the expression of enzymes such as fatty acid 
synthase, was reduced by EGCG (Fig. 5C). It is known that SREBP is activated by Akt, and it regulates the 
expression of cholesterol and fatty acid synthetic enzymes (Hua X et al 1993). We also showed that ROSs 
induce SREBP1c transcriptional activity (Sekiya M et al 2008). These findings indicate that the antioxidant 
effect of EGCG possibly reduces the transcriptional activity of SREBP1c. In addition, we propose that the 
transcription of FoxO and SREBP1c is controlled by the same signaling pathway since catechin reduces the 
transcriptional activity of both FoxO and SREBP1c. 
The findings of this study indicate that the antioxidant effect of EGCG suppresses 3T3-L1 preadipocyte 
differentiation by reducing the transcriptional activity of FoxO1 and SREBP1c via the insulin signaling 
pathway. Future studies on the inhibitory mechanism of green tea catechin on insulin signaling and FoxO may 
aid in the prevention of diabetes and obesity.   
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Figure Legends 
 
Fig. 1 Effect of catechin on adipocyte differentiation 
(A) Adipose accumulation was observed in the cells treated with EGCG or ECG (0, 50, 100, 200 µM). Cells 
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were treated by EGCG or ECG with DMI for 2 days. Then cells were cultured for 2 days with insulin (5 µg/ml) 
and 4 days in standard medium, cells were fixed for Oil Red O staining. (B) The Oil Red O stained cells (100 
µM of EGCG, ECG, EGC, CG) were treated with isopropanol to extract the dye, and the concentration of the 
eluted dye was determined by measuring the absorbance at O.D. 420 nm. An error bar shows standard 
deviation of the mean, n = 3; **P < 0.05. (C) Cells were treated by EGCG (100 µM), ECG (100 µM) or NAC 
(10 mM) with DMI for 2 days. Then cells were cultured for 2 days with insulin (5 µg/ml) and 4 days in 
standard medium. Lipid was then extracted by using the Bligh and Dyer methods (Bligh EG and Dyer WJ 
1959). Triglyceride level was corrected by total protein level. An error bar shows standard deviation of the 
mean, n = 3; **P < 0.05. 
 
Fig. 2 Effect of catechin on GPDH activity 
Cells were treated by catechin (100 µM of EGCG, ECG, EGC and CG) with DMI for 2 days. Then cells were 
cultured for 2 days with insulin (5 µg/ml) and 4 days in standard medium, and GPDH activity was analyzed. 
An error bar shows standard deviation of the mean, n = 3; ** P < 0.05. 
 
Fig. 3 Effect of catechin on glucose uptake 
Cells were treated by EGCG (100 µM) or ECG (100 µM) with DMI for 2 days. Then cells were cultured for 2 
days with insulin (5 µg/ml) and 4 days in standard medium: Glucose uptake was analyzed by treating cells with 
fluorescent-labeled glucose 2-NBDG (10 µM) for 5 min. The bright field (left) and fluorescent field (right) are 
shown. Fluorescence densities were quantified with the image J, and it was shown in graph as relative value 
against control ((-) 0 day). 
 
Fig. 4 Effect of catechin on fatty acid uptake 
Cells were treated by EGCG (100 µM) or ECG (100 µM) with DMI for 2 days. Then cells were cultured for 2 
days with insulin (5 µg/ml) and 4 days in standard medium: Fatty acid metabolism was analyzed by measuring 
fatty acid incorporation in cells treated with the fluorescent-labeled fatty acid analog BODIPY3823 (20 µM) 
for 2 min. The bright field (left) and fluorescent field (right) are shown. Fluorescence densities were quantified 
with the image J, and it was shown in graph as relative value against control ((-) 0 day). 
 
Fig. 5 Effect of catechin on transcriptional activity of FoxO1 and SREBP1c 
(A) Luciferase activity in the cell treated with EGCG was indicated. Cells were transfected with FoxO1 
expressing plasmid (pcDNA3-FoxO1, 0.25 µg/dish), luciferase reporter plasmid with a consensus sequence of 
FoxO1 binding site (IRS-Luc, 0.5 µg/dish) and β-galactosidase expressing plasmid (PCMV-β-gal, 0.25 
µg/dish). (-) indicates the cell transfected with these plasmids except FoxO1 expressing plasmid. After 45 hrs 
incubation, cells were treated with EGCG (0, 10, 20, 50 100 µM) for 3 hrs and analyzed for luciferase assay. 
Luciferase activity was corrected by β-galactosidase activity. An error bar shows standard deviation of the 
mean, n = 6; **P < 0.05. (B) The luciferase activity of catechin-treated cells is shown. 3T3-L1 cells which 
stably carry a luciferase reporter plasmid with a FoxO1 binding site (3T3-L1/Catalase-Luc) were treated with 
catechin (100 µM of EGCG, ECG, EGC), resveratrol (RES, 100 µM), and NAC (10 mM) for 2 days. An error 
bar shows the standard deviation of the mean, n = 3; **P < 0.05. (C) The luciferase activity of the 
catechin-treated cells is shown. 3T3-L1 cells which stably carry a luciferase reporter plasmid with a SREBP1c 
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binding site (3T3-L1/SRE-Luc) were treated with catechin (100 µM of EGCG, ECG, EGC), resveratrol (RES, 
100 µM), and NAC (10 mM) for 2 days. An error bar shows standard deviation of the mean, n = 3; **P < 0.05. 
 
Fig. 6 Effect of catechin on mRNA expression and phosphorylation  
(A) The mRNA level of each gene was analyzed by real-time PCR. Cells were treated with EGCG (100 µM) or 
NAC (10 mM) with DMI for 2 days. After 8 days culture, RNA was extracted for real-time PCR assay. (B) The 
mRNA level of each gene was analyzed by RT-PCR. Cells were treated by EGCG (100 µM) or NAC (10 mM) 
with DMI for 2 days, and RNA was extracted for RT-PCR assay. GAPDH was used as an internal RNA control. 
(C) The protein levels of FoxO1 and phosphorylated FoxO1 (Thr24, Ser256) were analyzed by western blot 
assay. Cells were treated by EGCG (100 µM), ECG (100 µM) or NAC (10 mM) with DMI for 2 days, and 
proteins analyzed by western blot analysis were treated with antibodies against FoxO1 (78 to 82kDa), 
phospho-FoxO1 (Thr24, 78 to 82 kDa), and phospho-FoxO1 (Ser256, 82 kDa). β-actin was used as a loading 
control. Band densities were quantified with the image J, and it was shown in graph as relative value against 
control ((-) FoxO1).  
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